Sramana Mitra: What is the dataset? Across all these categories, how many drugs and treatments are we talking about that you have modeled and have data for?
Sungwon Lim: Our first service which we commercialized last year is for dog blood cancer. What we are trying to do is help doctors make decisions. The 16 drugs that are used for lymphoma and leukemia are being tested on our platform. We collect the real-world actual treatment cases and provide our reports today.
>>>Marc Vontobel: Without having very good positioning, we already created traction and signed some big deals with some Fortune 500 companies. That helped us find out the real use cases where we can have a real impact on the business. If you buy Starmind without having a clear use case in mind, you always depend on the vision of the buyer. We have found a few of those, but it’s not repeatable.
Sramana Mitra: That’s a very rare buyer who can take a technology and find an application for it. That’s not the way to build a company at all.
>>>Wonderful story of cutting edge application of AI in cancer treatment.
Sramana Mitra: Let’s start by introducing our audience to yourself, a bit of your background, and then ImpriMed.
>>>Sramana Mitra: Coming up with the product idea is one thing, but productizing and building a business is quite a different thing. This is where, I think, you made a choice of going the B2C route. You pivoted to B2B where you found more success. What was your experience of the business side of it? How did you learn what you needed to learn?
Marc Vontobel: First of all, a big mistake a lot of founders do at the beginning is to believe that the first idea is to be proven right. In many cases, the first idea may be the spark. The more you talk to people, you figure out it wasn’t exactly the right thing. You have to listen and open up.
>>>Marc is yet another techie who has made a successful transition to being an entrepreneur.
In this interview, he discusses his journey, as well as a lot of the nuances of positioning his venture, Starmind, for success.
Sramana Mitra: Let’s start by introducing our audience to yourself as well as to Starmind.
>>>If you haven’t already, please study our free Bootstrapping course and the Investor Introductions page.
I am always thrilled to see great entrepreneurship in various parts of the world that are off-center. Well, Algo Founder and CEO Amjad Hussain’s journey is a great one from Detroit.
Sramana Mitra: Let’s start at the very beginning of your journey. Where are you from? Where were you born, raised, and in what kind of background?
Amjad Hussain: I was born in a very small village of Pakistan.
I did a startup in 1998 by applying AI to the lead generation and qualification problem. It was early. The data was not yet rich enough.
Now, the data is there. Can the problem finally be solved at the right level of sophistication?
Sramana Mitra: Let’s go to the very beginning of your journey. Where were you born and raised?
>>>Valon is a software developer who made a successful transition to an entrepreneur and had a quick exit with his first venture.
His second venture is already at $5M+ in revenues with just a pre-seed round of financing. This venture, Behemics, has already received two acquisition offers. Fabulous story!
>>>